Axcelis Technologies, Inc. (ACLS) | The Buildout — AI Infrastructure

——Mkt cap — · 52-wk —–— · YTD — · delayed

Updated Sep 22, 2026Q2 FY2026 reviewed

Axcelis Technologies makes ion implantation equipment and aftermarket services used to fabricate semiconductor chips, an embedded supplier into AI-driven memory, data-center power and mature-node chip demand.

Guide: +mid-single digits

FY2026 revenue growth now seen at approximately mid-single digits vs prior flat.

Q2 rev $215.2M

Systems $132M and CS&I $83M both exceeded forecast.

CS&I 39% of rev

Aftermarket grew more than 30% year over year in Q1 2026.

China 46% of rev

Up from 40% in Q1; includes Entity-List customer SMIC.

The Buildout Takeaway

The forward framing changed direction inside a single quarter: management went from expecting approximately flat 2026 revenue to mid-single-digit growth, and added a 2027 growth call, on memory, power and aftermarket strength together. The open question is memory, which management says will look similar in the second half to the first until customers' new cleanroom space comes online.

Analyst coverage

13 analysts·10 Buy2 Hold1 Sell

Coverage is thin — only 1 price estimate, so no target is shown

Management guidance

FY2026 revenue growth approximately mid-single digits year-over-year · Q3 2026: revenue ~$230M · gross margin ~43% · operating expenses ~$62M · adjusted EBITDA ~$41M · tax ~15% · EPS ~$1.11 · FY2026 tax rate ~15%.

Important: The Buildout is a data analytics platform. Content is generated by algorithms and AI agents using public filings, earnings transcripts, and market data. This is not personalized investment advice.

Our View

The Verdict

The company designs, builds and services ion implantation tools, the equipment that fires dopant ions into a silicon wafer to set its electrical properties. That is a core front-end wafer-fab step that recurs across nearly every device type, and it is the source of nearly all of the company's revenue. It also runs an aftermarket business selling used tools, spare parts, upgrades and maintenance against its installed base. AI reaches Axcelis indirectly rather than through a named AI product: customers building DRAM and high-bandwidth memory, power devices for data-center power architectures, and data-center chips on mature process nodes are all buying implant capacity. Management describes the demand base as predominantly mature-node, with memory the largest growth engine.

Market Cap	—
Revenue (TTM)	$866M
Revenue Growth	−3.3%
EBITDA Margin (TTM)	12.4%

Net Cash	$361M
Earnings Beats	7 of 7
P/E (TTM)	—
EV/EBITDA (TTM)	—

What We Like

Guidance moved one way: FY2026 revenue was raised from approximately flat to approximately mid-single-digit growth, Q4 2026 sequential growth is expected, and management says it anticipates another year of revenue growth in 2027.
Aftermarket (CS&I) revenue was $83M in Q2 2026, about 39% of total, after growing more than 30% year over year in Q1 — a base that grows with the installed base and customer utilization.
Memory orders progressed: a leading North American memory manufacturer went from order to completed evaluation to additional orders for new fab investments, and the company booked an order for multiple high-current systems in Q2 2026.
Power flipped from digestion to recovery: H1 2026 silicon-carbide bookings exceeded the average of the past two years, two new China customers were added, and management guides the second half stronger than the first.
Balance sheet and capacity: $577M of cash and marketable securities at the Q2 2026 exit, with a finance lease the only debt, and management confirmed existing capacity supports higher revenue than today's run rate and would bring a modest gross-margin absorption benefit. The company also has a track record of reporting earnings ahead of analyst estimates.

What We’re Watching

Memory is gated on customer cleanroom space. Management says second-half 2026 memory probably looks similar to the first half, and the 2027 momentum call depends on new cleanroom space coming online.
Gross margin has missed the guided figure two quarters running: Q1 2026 at 40.7% non-GAAP versus about 41%, on a $5M customer settlement, and Q2 2026 at 42.7% versus about 43%, on CS&I mix and higher services costs. Memory systems carry below-corporate-average system gross margin, and the mix is tilting toward memory.
General-mature order rates have not picked up. Q3 2026 revenue is guided to see a lower general-mature contribution, and FY2026 general mature is expected down year over year.
The Veeco merger's only remaining approval is China's SAMR, targeted for the second half of 2026. All transaction Q&A is deferred by policy, and the CFO is interim.

Bottom Line

The revenue side of the case strengthened this quarter. The full-year guide reversed direction, Q3 revenue is guided higher, Q4 is expected up sequentially, and management put a 2027 growth year on the record. The margin side is not yet proven: two consecutive guided-margin misses, on a growth mix tilting toward below-corporate-average memory systems. The structural exposures are unchanged and overlapping — three customers were 19.8%, 13.7% and 10.7% of Q1 2026 revenue, and China was 46% of Q2 revenue including a named Entity-List customer operating under a 2020 licensing policy. The open question is whether memory revenue actually moves off its first-half plateau as cleanroom space arrives, and whether gross margin holds at the guided level when it does.

Next upThe Q3 2026 print is the first test of the raised guide, against revenue of approximately $230M, gross margin of approximately 43% and EPS of approximately $1.11. It tests both whether the demand broadening is real and whether margin can be met rather than missed.

Last Quarter — Q2 FY2026

Earnings Beat

Axcelis reported Q2 2026 revenue of $215.2M on 2026-08-06, above expectations, with systems and aftermarket both above forecast. Gross margin was 42.4% GAAP and 42.7% non-GAAP, slightly below the guided 43% on mix within the CS&I business and higher-than-anticipated services costs. Non-GAAP diluted EPS was $1.06 and adjusted EBITDA was $36M, or 16.7% of revenue. Backlog exiting the quarter was $452M with bookings of $131M, a book-to-bill of about 1x.

Metric	Q2 FY2026	Q1 FY2026	Q2 FY2025	YoY
Revenue	$215M	$199M	$194M	+10.6%
Gross margin	42.4%	40.5%	44.9%	-250bps
EBITDA	$25M	$12M	$34M	−26.3%
EPS	$0.75	$0.30	$0.98	−23.4%
Bookings	$131M	$128M	n/a	—
Backlog	$452M	$453M	n/a	—

second half for memory, probably at this point, probably looks similar to the first half.— David Ryzhik, SVP & Interim CFO, 2026-08-06

Management tone: The tone shifted across one quarter. The Q1 2026 call (2026-05-07) was steady and cautious: full-year 2026 revenue expected approximately flat, power and general mature described as digesting, and a CFO departure announced. The Q2 2026 call (2026-08-06) was more constructive: the full-year guide was raised to approximately mid-single-digit growth, power was reframed from digestion to recovery, general mature to the embers of a recovery, and Q4 sequential revenue growth was put on the table along with a 2027 growth year. Management kept the near-term tempering alongside the raise, saying second-half memory likely looks like the first half, that NAND is not yet a trend, and that general-mature order rates have not turned.

Management Guidance

For Q3 2026 management guides revenue of approximately $230M, gross margin of approximately 43%, operating expenses of approximately $62M, adjusted EBITDA of approximately $41M, a tax rate of approximately 15% and EPS of approximately $1.11. Q3 is expected to benefit from a higher contribution from power and memory, partly offset by lower general-mature revenue. For Q4 2026, revenue is expected to increase sequentially, gross margin to improve slightly versus Q3, and operating expenses to be slightly higher. Full-year 2026 revenue growth is guided to approximately mid-single digits year over year, raised from a prior expectation of flat revenue, with a tax rate of approximately 15% and a gross margin in the low- to mid-40% range.

Business Trajectory

Trajectory

Revenue has moved $194.5M (Q2 FY2025), $213.6M, $238.3M, $199.0M (Q1 FY2026) and $215.2M (Q2 FY2026), and management guides Q3 2026 to approximately $230M with Q4 higher again. On the reported basis in reported figures — operating income plus depreciation and amortization — EBITDA went from $12.4M, or 6.2% of revenue, in Q1 FY2026 to $24.7M, or 11.5%, in Q2, and gross margin from 40.5% to 42.4%, against a 46.1% gross margin in Q1 FY2025. The drivers management cites are memory strength, a power recovery and a growing aftermarket; the drags are memory systems carrying below-corporate-average margin, a $5M customer settlement in Q1, and Veeco transaction costs in both quarters.

Revenue & Margin Trajectory

Gross margin as reported.

Share Price — 12 Months

52-week range $78–$189.

Share Price — 12 Months

52-week range $78–$189.

The Numbers

The Model

The model projects FY+1 revenue of 885M with EBITDA of 131M, a 14.8% margin, and FY+2 revenue of 970M with EBITDA of 162M, a 16.7% margin. The near-term figure rests on the demand cadence management has already guided: higher power and memory contributions in the third quarter, sequential revenue growth in the fourth, and an aftermarket base that has been growing faster than systems. The step up in FY+2 depends on memory moving past the cleanroom gate into 2027, silicon-carbide revenue improving through the second half and beyond, more than a little volume absorption on capacity that is already installed, and the mix not working as hard against gross margin.

Revenue & EBITDA Projections

Solid bars are reported actuals; outlined bars are model projections — not company guidance.

Metric	FY2025	Next FY (E)	Following FY (E)
Revenue	$839M	$885M	$970M
YoY Growth	—	+5.5%	+9.6%
EBITDA	$137M	$131M	$162M
EBITDA Margin	16.3%	14.8%	16.7%

Projections are the median of 5 independent model runs. The model’s revenue sits 5.9% above analyst consensus.

What Could Go Right — and Wrong

What good looks like

Memory revenue breaks out of its first-half plateau as customers bring new cleanroom space online, supporting the 2027 growth call.
General-mature order rates turn, converting improving utilization into system orders and giving the 2027 growth call a third leg.
Gross margin reaches and holds the guided level, with volume absorption on existing capacity showing up in cost of revenue.
The Purion XEmax evaluation at a leading foundry for power-management IC production converts into orders.
The Veeco merger closes in the second half of 2026 on SAMR approval, adding MOCVD adjacency and reopening the disclosure channel.

What could go wrong

Memory cleanroom construction slips, leaving second-half 2026 at first-half levels and the 2027 growth call without support.
A third consecutive gross-margin miss on mix and services costs, as the growth mix tilts toward below-corporate-average memory systems.
General-mature order rates stay flat and FY2026 general-mature revenue finishes down year over year.
China policy moves around the SMIC licensing policy, against a 46% China revenue mix and three customers at roughly 44% of a quarter's revenue.
The Veeco transaction fails or slips past the second half of 2026, with China's SAMR approval the last remaining condition for closing.

What’s Next

Looking Ahead

The next twelve months turn on a few tests. The Q3 2026 print has to show the guided revenue and the guided gross margin landing together; Q4 has to deliver the sequential revenue increase management has already put on the record; and FY2026 has to close at approximately mid-single-digit revenue growth. Underneath those, the questions are whether memory moves past its cleanroom gate into 2027, whether general-mature orders finally turn, and whether China's SAMR clears the Veeco merger in the second half of 2026. Elsewhere, a $35M new manufacturing facility in Pyeongtaek, Korea was announced on 2026-09-08 with no stated completion date, and the search for a permanent CFO remains undated.

Catalysts

Q3 2026Q3 2026 results — First print under the raised FY guide; Q3 is guided to benefit from higher power and memory, partly offset by lower general mature.
H2 2026Veeco merger close — Gated on China SAMR approval, the last remaining condition for closing.
Q4 2026Q4 sequential revenue — Management expects revenue to rise sequentially and margin to improve slightly.
20272027 growth year — Management anticipates another year of revenue growth, at a lower memory rate.
No date statedPyeongtaek facility — $35M Korean ion-implant plant announced 2026-09-08; no completion date.
Not datedPermanent CFO — David Ryzhik is interim; the search is ongoing and undated.

Numbers

Financials

Annual Summary

Metric	FY2024	FY2025	TTM	YoY
Revenue	$1.0B	$839M	$866M	-17.6%
Gross Margin	44.7%	44.9%	43.0%	+23bps
EBITDA	$227M	$137M	$107M	-39.6%
EBITDA Margin	22.3%	16.3%	12.4%	594bps
Net Income	$201M	$120M	$93M	-40.2%
Free Cash Flow	$129M	$107M	$66M	—
Net Cash	—	—	—	—

Key Ratios (Trailing)

Valuation

P/E TTM—
EV/EBITDA TTM—
EV/Revenue TTM—
Price/FCF TTM—

Profitability

Gross Margin (TTM)43.0%
EBITDA Margin (TTM)12.4%
Net Margin (TTM)10.7%
ROIC10.0%
FCF Conversion61.2%
SBC / Revenue2.5%

Reference

The Company

Axcelis designs, manufactures and services ion implantation and other processing equipment used in semiconductor chip fabrication. Ion implantation is the front-end step that physically fires dopant ions into a silicon wafer to set its electrical properties, and it recurs across essentially every device type. The FY2025 10-K states that the ion implantation business represented 98.2% of revenue in 2025, and that the company sells to semiconductor chip manufacturers worldwide with extensive aftermarket lifecycle products and services.

The company reports two named lines: Ion Implantation Systems, which the 10-K describes as a complete line of high energy, high current and medium current implanters for all application requirements, and Aftermarket Support and Services, covering used tools, spare parts, equipment upgrades and maintenance. The product map runs from the Purion H, Purion Dragon, Purion H200 and GSD/E2 Ovation high-current tools through the Purion XE and Purion EXE high-energy systems, batch Ovation platforms, Purion M Si and Purion M SiC medium-current tools, the Purion Power Series for power devices, and the Purion H6 high-current platform introduced in Q1 2026. All three named facilities are leased: the 417,000 sq ft principal site in Beverly, Massachusetts, a 101,800 sq ft logistics and flex manufacturing center there, and a 38,000 sq ft Asia Operations Center in South Korea. The company ended Q2 2026 with $577M in cash, cash equivalents and marketable securities.

Business Segments

Ion Implantation Systems

$132M of Q2 2026 revenue

A complete line of high energy, high current and medium current implanters for all application requirements, per the 10-K.

Growth driver: Memory and power capacity additions

Aftermarket Support and Services (CS&I)

$83M of Q2 2026 revenue

Used tools, spare parts, equipment upgrades and maintenance services sold against the installed base.

Growth driver: Installed base, utilization and upgrades

Competitive Landscape

The FY2025 10-K is specific about the competition: in the market for ion implantation systems, the company mainly competes against Applied Materials, Inc. It also names Sumitomo Heavy Industries Ion Technology and Nissin Ion Equipment in Japan, Advanced Ion Beam Technology in Taiwan, and Kingstone Semiconductor and CETC Electronics Equipment Group in China. The picture the source supports is a focused single-process specialist against one broad-line leader plus a set of regional and emerging suppliers, two of them Chinese, in a market where China was 46% of Axcelis revenue in Q2 2026.

Applied Materials
The 10-K says Axcelis mainly competes against it, the only competitor the filing describes as a main one. Neighbor read-through: FY26 Q3 revenue of $9.1B with DRAM up 52% year over year.
Sumitomo Heavy Industries Ion Technology
Named in the 10-K as a Japan-based competitor; not discussed further.
Nissin Ion Equipment
Named in the 10-K as a Japan-based competitor; not discussed further.
Advanced Ion Beam Technology
Named in the 10-K as a Taiwan-based competitor; not discussed further.
Kingstone Semiconductor; CETC Electronics Equipment Group
Named in the 10-K as China-based competitors; not discussed further.

All competitor names come from the FY2025 10-K; only Applied Materials is described beyond the naming, as the main competitor.

Supply Chain

Axcelis buys components and sub-assemblies from outside vendors and sells implant tools and aftermarket parts and services into chip fabs. The 10-K describes reliance on a limited group of suppliers. No supplier relationship carries a documented company disclosure, so the named supplier map below is inferred.

Supplier

Advanced Energy (AEIS)

RF power delivery and plasma generation subsystems

Supplier

MKS (MKSI)

RF power delivery, gas management, vacuum subsystems, process control

Supplier

Entegris (ENTG)

Specialty chemicals, gas filtration, process materials, dopant pellets

Supplier

Amphenol (APH)

Cables and connectors